SCPHARMACEUTICALS INC. Lessee, Operating Lease, Liability, to be Paid
SCPHARMACEUTICALS INC. had Lessee, Operating Lease, Liability, to be Paid of $1.56 million as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2025-08-07
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid $1.56M.
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid $1.66M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid $1.73M.
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid $1.83M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2025-06-30 | $1.56M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.66M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.73M 10-K · filed 2025-03-19 |
| 2024-09-30 | $1.83M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.83M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.92M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $2.00M 10-K · filed 2024-03-13 |
| 2023-09-30 | $2.14M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $281.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $443.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $606.00K 10-K · filed 2023-03-22 |
| 2022-09-30 | $757.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $892.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $388.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $496.00K 10-K · filed 2022-03-22 |
| 2021-09-30 | $629.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $761.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $897.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.03M 10-K · filed 2021-03-23 |
| 2020-09-30 | $1.17M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $1.30M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $1.43M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $1.56M 10-K · filed 2020-03-24 |
| 2019-09-30 | $1.69M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.82M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.95M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $2.07M 10-K · filed 2019-03-21 |
| 2018-09-30 | $2.20M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $2.27M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.37M 10-Q · filed 2018-05-07 |